Fran Crawford has been closely involved in the growth of several life science businesses including Altacor, Sirus Pharmaceuticals , Spirogen and Ethical Holdings PLC. She has participated in M&A and in creating exits for the benefit of shareholders and investors. Fran is a PhD clinical pharmacologist who, following two post-doctoral posts entered the pharmaceutical industry in clinical research with Ethical Holdings. She has an extensive record of product development and regulatory approvals (formulation to market) in Europe and the US as well as in- and out-licensing. Holding senior posts in several start-up businesses she has built IP portfolios to add value and protection to product pipelines. For ten years she was responsible for growing hospital and retail sales teams to commercialise products in a Specialty Pharma setting. She is strongly entrepreneurial having founded Altacor, advised on founding Somanautix and developed a network in the funding and grant arenas.